ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haworth, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haworth, W. S.
Related Collections
Right arrow History

Ann Thorac Surg 2003;76:S2216-S2219
© 2003 The Society of Thoracic Surgeons


Supplement: Gibbon & His Heart-Lung Machine

The development of the modern oxygenator

William S. Haworth, DPhila*

a Cachet Medical Limited, Columbia Heights, Minnesota, USA

* Address reprint requests to Dr Haworth, 4022 7th St NE, Columbia Heights, MN 55421, USA.
e-mail: billhaworth{at}aol.com

Presented at the symposium, "Gibbon & His Heart-Lung Machine: 50 Years & Beyond," Philadelphia, PA, May 2, 2003.

Abstract

From 1953 when Gibbon first successfully supported a patient with extracorporeal circulation to about 1980 many different types of oxygenators were developed. Since their introduction in the early 1980s, microporous hollow fiber oxygenators with blood flow outside the fiber have become the dominant type of oxygenator in use. Their success has been due to both the ability to specify the required properties for a good oxygenator and the application of modern design tools, especially computational fluid dynamics, to the design process. The result has been the availability of many oxygenators from different manufacturers that differ to some extent in their performance but all of which provide adequate performance for successful and safe clinical use.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. M. Hoganson, J. L. Anderson, E. F. Weinberg, E. J. Swart, B. K. Orrick, J. T. Borenstein, and J. P. Vacanti
Branched vascular network architecture: A new approach to lung assist device technology
J. Thorac. Cardiovasc. Surg., November 1, 2010; 140(5): 990 - 995.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. S. Murphy, E. A. Hessel II, and R. C. Groom
Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach
Anesth. Analg., May 1, 2009; 108(5): 1394 - 1417.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 by The Society of Thoracic Surgeons.